Jun 15, 2026 08:30AM
May 13, 2026 04:02PM
May 11, 2026 04:02PM
Apr 16, 2026 08:50AM
Apr 16, 2026 08:45AM
Mar 31, 2026 04:02PM
Mar 26, 2026 08:45AM Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
Mar 21, 2026 03:23AM
Feb 17, 2026 08:45AM
Jan 27, 2026 09:02AM
Jan 27, 2026 09:00AM
Dec 29, 2025 05:11AM
Dec 26, 2025 06:36PM
Dec 24, 2025 10:40AM Omeros stock soars after FDA approves first treatment for TA-TMA
Dec 24, 2025 09:00AM
Dec 24, 2025 09:00AM
Dec 1, 2025 08:30AM
Dec 1, 2025 08:30AM
Nov 13, 2025 04:11PM
Nov 11, 2025 08:30AM
Oct 16, 2025 08:33AM Omeros publishes study showing survival benefits of narsoplimab treatment
Oct 16, 2025 08:30AM
Oct 15, 2025 08:30AM
Sep 2, 2025 08:45AM
Sep 2, 2025 08:45AM
Aug 14, 2025 04:02PM
Aug 11, 2025 04:02PM
Jul 25, 2025 08:00AM Omeros prices $22 million direct offering at 14% premium
Jul 25, 2025 08:00AM
Jun 27, 2025 08:31AM
Jun 27, 2025 08:30AM
Jun 24, 2025 08:30AM
May 15, 2025 04:05PM
May 12, 2025 05:05PM
May 12, 2025 08:41AM Omeros (OMER) Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026
May 12, 2025 08:41AM
May 6, 2025 09:16AM
May 6, 2025 09:16AM
Apr 10, 2025 09:10AM
Apr 10, 2025 09:10AM
Apr 8, 2025 09:00AM
Mar 31, 2025 04:02PM Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results
Mar 26, 2025 09:15AM
Mar 21, 2025 09:15AM
Mar 21, 2025 09:15AM
Mar 13, 2025 09:00AM
Feb 20, 2025 09:11AM
Feb 20, 2025 09:10AM
Feb 14, 2025 09:00AM Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings
Feb 10, 2025 09:00AM

323,123 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All